Cell Saver in Adult Spinal Deformity Surgery: Helping or Hurting?

Neurosurgery 2026

View at publisher
Authors: Harsh Jain, Ranbir Ahluwalia, Advith Sarikonda, Sameer Sundrani, Omar Zakieh, Alexander T. Lyons, Sakshi Krishna, Tag Alsir Osama, Austin Montogomery, Walter Navid, Tyler C. Zeoli, Iyan Younus
+6 more Soren Jonzzon, Hani Chanbour, Julian G. Lugo-Pico, Amir M. Abtahi, Byron F. Stephens, Scott L. Zuckerman
DOI: 10.1227/neu.0000000000003909
Cited by: 1
References: 29

Abstract

BACKGROUND AND OBJECTIVES: While Cell Saver (CS) is meant to give patients back their own blood products in surgery, its quality has been called into question. To determine the safety of CS in adult spinal deformity (ASD) surgery, we sought to evaluate the impact CS on (1) intraoperative transfusions, (2) postoperative hematocrit, and (3) complications. METHODS: A retrospective cohort study (2009-23) was performed for patients undergoing ASD surgery. Inclusion criteria were ≥5-level fusion, sagittal/coronal deformity, and ≥2-year follow-up. Primary exposure was use of CS. Primary outcomes were (1) intraoperative transfusions, (2) postoperative hematocrit, and (3) overall complications. Secondary outcomes were intraoperative hypotension, defined as total minutes mean arterial pressure was

Fields of Study & Subjects

Blood transfusion and management Hemostasis and retained surgical items Trauma Hemostasis Coagulopathy Resuscitation

Publication details

Journal / source
Neurosurgery
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
99
Issue
4
Pages
760–767
Publication date
27 January 2026
Language
EN